Skip to main content
Clinical Trials/NCT05353114
NCT05353114
Completed
Not Applicable

Clinical Efficacy of a 3D Foot Scanner App for the Fitting of Therapeutic Footwear in Persons With Diabetes in Remission: A Randomized and Controlled Clinical Trial.

Universidad Complutense de Madrid1 site in 1 country30 target enrollmentJune 15, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Foot
Sponsor
Universidad Complutense de Madrid
Enrollment
30
Locations
1
Primary Endpoint
The primary outcome measure was the requirement of Therapeutic Footwear change after prescription because ill fitting.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Patients with diabetes at high risk of ulceration require a perfect fitting shoe to avoid high shear and pressure forces. Neuropathy skews sensory perceptions and can alter the proper selection of the therapeutic footwear.

The aims of study were to evaluate the ability of high-risk patients with diabetes in remission to select the proper therapeutic footwear and to validate a novel 3D foot scanner app for selecting the proper fitting therapeutic footwear.

Detailed Description

A Randomized Controlled Clinical Trial in 30 patients with a previous healed diabetic foot ulcer. After parallel randomization (1:1) patients will be enrolled into two different groups: 1. Patients that will acquire the therapeutic footwear size and model according to aesthetic preferences; 2. Patients that will acquire a specific size and model according to result of a novel mobile app 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy). Validation of proper therapeutic footwear fitting will be performed by a specialized podiatrist after acquisition of shoes in both groups. Therapeutic Footwear will be recommended to change when following ill fitting reason been found: excessive length or tight, or compromise with toes

Registry
clinicaltrials.gov
Start Date
June 15, 2022
End Date
July 15, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jose Luis Lazaro Martinez

Prof. Dr

Universidad Complutense de Madrid

Eligibility Criteria

Inclusion Criteria

  • High risk patients according to the International Working Group Diabetic Foot Guidelines (IWGDF-risk 3).
  • Healed diabetic foot ulcer at the moment of inclusion.
  • Capability to walk autonomously without walking aids.
  • Diabetic Peripheral neuropathy.

Exclusion Criteria

  • Major amputation in the contralateral limb (below or above the knee).

Outcomes

Primary Outcomes

The primary outcome measure was the requirement of Therapeutic Footwear change after prescription because ill fitting.

Time Frame: 1 week

Validation of proper therapeutic footwear fitting was performed by a specialized podiatrist after acquisition of shoes in both groups. TF was recommended to change when following ill fitting reason were found: excessive length or tight, or compromise with toes

Secondary Outcomes

  • Number of participants with an ulcer occurrence event(1 month)

Study Sites (1)

Loading locations...

Similar Trials